OTCPK:ULIHF (Hong Kong)
Â
Ordinary Shares
$
0.89
0 (0%)
10:09 PM EST
Current and historical daily PE Ratio for United Laboratories International Holdings Ltd (
) from 2011 to May 29 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. United Laboratories International stock (ULIHF) PE ratio as of May 29 2024 is 5.56.
More Details
United Laboratories International Holdings Ltd (ULIHF) PE Ratio (TTM) Chart
United Laboratories International Holdings Ltd (ULIHF) PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 1236
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| United Laboratories International PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-29 | 4.3 | 2024-03-25 | 4.3 |
| 2024-05-28 | 4.3 | 2024-03-22 | 4.3 |
| 2024-05-24 | 4.3 | 2024-03-21 | 4.3 |
| 2024-05-23 | 4.3 | 2024-03-20 | 4.3 |
| 2024-05-22 | 4.3 | 2024-03-19 | 4.3 |
| 2024-05-21 | 4.3 | 2024-03-18 | 4.3 |
| 2024-05-20 | 4.3 | 2024-03-15 | 4.3 |
| 2024-05-17 | 4.3 | 2024-03-14 | 4.3 |
| 2024-05-16 | 4.3 | 2024-03-13 | 4.3 |
| 2024-05-15 | 4.3 | 2024-03-12 | 4.3 |
| 2024-05-14 | 4.3 | 2024-03-11 | 4.3 |
| 2024-05-13 | 4.3 | 2024-03-08 | 4.3 |
| 2024-05-10 | 4.3 | 2024-03-07 | 4.3 |
| 2024-05-09 | 4.3 | 2024-03-06 | 4.3 |
| 2024-05-08 | 4.3 | 2024-03-05 | 4.3 |
| 2024-05-07 | 4.3 | 2024-03-04 | 4.3 |
| 2024-05-06 | 4.3 | 2024-03-01 | 4.3 |
| 2024-05-03 | 4.3 | 2024-02-29 | 4.3 |
| 2024-05-02 | 4.3 | 2024-02-28 | 4.3 |
| 2024-05-01 | 4.3 | 2024-02-27 | 4.3 |
| 2024-04-30 | 4.3 | 2024-02-26 | 4.3 |
| 2024-04-29 | 4.3 | 2024-02-23 | 4.3 |
| 2024-04-26 | 4.3 | 2024-02-22 | 4.3 |
| 2024-04-25 | 4.3 | 2024-02-21 | 4.3 |
| 2024-04-24 | 4.3 | 2024-02-20 | 4.3 |
| 2024-04-23 | 4.3 | 2024-02-16 | 4.3 |
| 2024-04-22 | 4.3 | 2024-02-15 | 4.3 |
| 2024-04-19 | 4.3 | 2024-02-14 | 4.3 |
| 2024-04-18 | 4.3 | 2024-02-13 | 4.3 |
| 2024-04-17 | 4.3 | 2024-02-12 | 4.3 |
| 2024-04-16 | 4.3 | 2024-02-09 | 4.3 |
| 2024-04-15 | 4.3 | 2024-02-08 | 4.3 |
| 2024-04-12 | 4.3 | 2024-02-07 | 4.3 |
| 2024-04-11 | 4.3 | 2024-02-06 | 4.3 |
| 2024-04-10 | 4.3 | 2024-02-05 | 4.3 |
| 2024-04-09 | 4.3 | 2024-02-02 | 4.3 |
| 2024-04-08 | 4.3 | 2024-02-01 | 4.3 |
| 2024-04-05 | 4.3 | 2024-01-31 | 4.3 |
| 2024-04-04 | 4.3 | 2024-01-30 | 4.3 |
| 2024-04-03 | 4.3 | 2024-01-29 | 4.3 |
| 2024-04-02 | 4.3 | 2024-01-26 | 4.3 |
| 2024-04-01 | 4.3 | 2024-01-25 | 4.3 |
| 2024-03-28 | 4.3 | 2024-01-24 | 4.3 |
| 2024-03-27 | 4.3 | 2024-01-23 | 4.3 |
| 2024-03-26 | 4.3 | 2024-01-22 | 4.3 |
United Laboratories International Holdings Ltd (ULIHF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
United Laboratories International Holdings Ltd
ISIN : KYG8813K1085
Share Class Description:
ULIHF: Ordinary SharesCompare
Compare
Traded in other countries / regions
03933.Hong KongUNJ.GermanyULIHF.USA IPO Date
2011-03-03Description
United Laboratories International Holdings Ltd is a drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Majority of the company's sales are generated in China, followed by Europe, India and other countries.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers